Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine: Reply to comment from Doyle et al.
作者信息
Blickstein Dorit, Koren Michowitz Maya
机构信息
Department of Hematology, Shamir Medical Center, Zerifin, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
出版信息
J Thromb Haemost. 2022 Mar;20(3):783-784. doi: 10.1111/jth.15634.
Abstract
摘要
相似文献
1
Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine: Reply to comment from Doyle et al.获得性血栓性血小板减少性紫癜：一种与BNT162b2疫苗相关的罕见疾病：对多伊尔等人评论的回复
J Thromb Haemost. 2022 Mar;20(3):783-784. doi: 10.1111/jth.15634.
2
Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine: Comment from Doyle et al.获得性血栓性血小板减少性紫癜：一种与BNT162b2疫苗相关的罕见疾病：多伊尔等人的评论
J Thromb Haemost. 2022 Mar;20(3):781-783. doi: 10.1111/jth.15632.
3
Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine.获得性血栓性血小板减少性紫癜：一种与 BNT162b2 疫苗相关的罕见疾病。
J Thromb Haemost. 2021 Sep;19(9):2314-2317. doi: 10.1111/jth.15420. Epub 2021 Jul 7.
4
Acquired Thrombotic Thrombocytopenic Purpura Following BNT162b2 mRNA Coronavirus Disease Vaccination in a Japanese Patient.日本患者接种 BNT162b2 mRNA 冠状病毒病疫苗后获得性血栓性血小板减少性紫癜。
Intern Med. 2022 Feb 1;61(3):407-412. doi: 10.2169/internalmedicine.8568-21. Epub 2021 Nov 20.
5
Acquired Thrombotic Thrombocytopenic Purpura After BNT162b2 COVID-19 Vaccine: Case Report and Literature Review.接种 BNT162b2 新冠疫苗后获得性血栓性血小板减少性紫癜：病例报告和文献复习。
Lab Med. 2022 Nov 3;53(6):e145-e148. doi: 10.1093/labmed/lmac016.
6
Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy.儿童期和青少年期起病的获得性血栓性血小板减少性紫癜伴严重ADAMTS13缺乏症：法国全国血栓性微血管病登记处的一项队列研究
Lancet Haematol. 2016 Nov;3(11):e537-e546. doi: 10.1016/S2352-3026(16)30125-9. Epub 2016 Oct 3.
7
Immune-Mediated Thrombotic Thrombocytopenic Purpura after BNT162b2 Vaccine.BNT162b2疫苗接种后免疫介导的血栓性血小板减少性紫癜
Turk J Haematol. 2022 Feb 23;39(1):74-75. doi: 10.4274/tjh.galenos.2021.2021.0537. Epub 2021 Dec 10.
8
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine.首次接种BNT162b2 mRNA新冠疫苗后发生获得性血栓性血小板减少性紫癜。
Ann Hematol. 2022 Mar;101(3):717-719. doi: 10.1007/s00277-021-04584-y. Epub 2021 Jul 26.
9
A case of severe ADAMTS13 deficiency presenting as thrombotic thrombocytopenic purpura in pregnancy.一例以妊娠期血栓性血小板减少性紫癜为表现的严重ADAMTS13缺乏症病例。
Med Pregl. 2012 Sep-Oct;65(9-10):436-9. doi: 10.2298/mpns1210436n.
10
Inherited thrombotic thrombocytopenic purpura mimicking immune thrombocytopenic purpura during pregnancy: a case report.孕期表现为免疫性血小板减少性紫癜的遗传性血栓性血小板减少性紫癜：一例报告
J Med Case Rep. 2018 Jan 22;12(1):15. doi: 10.1186/s13256-017-1545-3.
本文引用的文献
1
Thrombotic thrombocytopenic purpura after ChAdOx1 nCoV-19 vaccine.接种 ChAdOx1 nCoV-19 疫苗后发生血栓性血小板减少性紫癜。
BMJ Case Rep. 2021 Oct 8;14(10):e246049. doi: 10.1136/bcr-2021-246049.
2
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel.以色列接种 BNT162b2 mRNA 疫苗后出现心肌炎。
N Engl J Med. 2021 Dec 2;385(23):2140-2149. doi: 10.1056/NEJMoa2109730. Epub 2021 Oct 6.
3
Recurrence of Thrombotic Thrombocytopenic Purpura after mRNA-1273 COVID-19 Vaccine Administered Shortly after COVID-19.新冠病毒感染后不久接种mRNA-1273新冠疫苗后血栓性血小板减少性紫癜复发
Case Rep Hematol. 2021 Sep 13;2021:4130138. doi: 10.1155/2021/4130138. eCollection 2021.
4
Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine.接种辉瑞-生物科技公司新冠疫苗后发生的免疫介导性血栓性血小板减少性紫癜
Haematologica. 2022 Apr 1;107(4):1008-1010. doi: 10.3324/haematol.2021.279535.
5
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine.首次接种BNT162b2 mRNA新冠疫苗后发生获得性血栓性血小板减少性紫癜。
Ann Hematol. 2022 Mar;101(3):717-719. doi: 10.1007/s00277-021-04584-y. Epub 2021 Jul 26.
6
Acquired thrombotic thrombocytopenic purpura with possible association with AstraZeneca-Oxford COVID-19 vaccine.获得性血栓性血小板减少性紫癜，可能与阿斯利康-牛津新冠疫苗有关。
EJHaem. 2021 May 18;2(3):534-536. doi: 10.1002/jha2.219. eCollection 2021 Aug.
7
Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine.获得性血栓性血小板减少性紫癜：一种与 BNT162b2 疫苗相关的罕见疾病。
J Thromb Haemost. 2021 Sep;19(9):2314-2317. doi: 10.1111/jth.15420. Epub 2021 Jul 7.
8
First report of a de novo iTTP episode associated with an mRNA-based anti-COVID-19 vaccination.首例与基于 mRNA 的抗 COVID-19 疫苗接种相关的新发免疫性血小板减少性紫癜（iTTP）发作。
J Thromb Haemost. 2021 Aug;19(8):2014-2018. doi: 10.1111/jth.15418. Epub 2021 Jul 5.
9
Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine.新冠疫苗接种后血栓性血小板减少性紫癜复发
Transfus Apher Sci. 2021 Aug;60(4):103145. doi: 10.1016/j.transci.2021.103145. Epub 2021 Apr 16.
10
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.接种 ChAdOx1 nCov-19 疫苗后发生血栓性血小板减少症。
N Engl J Med. 2021 Jun 3;384(22):2092-2101. doi: 10.1056/NEJMoa2104840. Epub 2021 Apr 9.
Zotero 插件